Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study

Anticardiolipin antibodies, one of the family of 'antiphospholipid' antibodies, increase the risk of venous thromboembolism in the presence of autoimmune disease. Our objective was to determine prospectively whether there is a positive association between anticardiolipin antibodies and venous thromboembolism in ostensibly healthy adults. We conducted a nested case-control study (n = 317 patients and n = 655 control subjects) in a longitudinal study of over 20 000 participants. Baseline (prediagnosis) anticardiolipin IgG and IgM antibodies were assessed by enzyme-linked immunoassays. Venous thromboembolism was validated using standardized criteria for venous thrombosis and pulmonary embolism. There was no association between anticardiolipin antibodies and subsequent venous thromboembolism occurrence, overall or in any subgroup. For example, the multivariate-adjusted relative risk was 0.88 (95% confidence interval, 0.43, 1.78) for greater than versus less than the 95th percentile of anticardiolipin IgG. In conclusion, in this general population sample, an elevated anticardiolipin antibody level was not a risk factor for venous thromboembolism.     

Human masticatory muscle activity and jaw position under experimental stress

The purpose of the present study was to determine whether stress induced a consistent pattern of increased electromyographic (EMG) activity in different masticatory muscles, and whether stress produced changes in jaw position. Thirty-five dental students at Taipei Medical College volunteered for this study. Mental arithmetic was used to create a stress condition and relaxation instruction was used to help relax the subjects. Subjects were asked to evaluate the stress they felt under each experimental condition with a visual analogue scale (VAS). Surface electrodes were used to monitor the EMG activities of the right masseter, right posterior temporalis and suprahyoid muscles. A kinesiograph was used to observe the jaw position. Data collected before mental arithmetic or relaxation monitored the baseline level. The VAS means were significantly increased during the stress condition and significantly decreased following relaxation, compared with the baseline. There was also a significant increase in EMG activity of all three muscles during mental arithmetic compared with baseline; different patterns of increased EMG activity were noticed in the three muscles under a continuous stress condition. Under stress, the incidence of tooth contact at intercuspal position was also increased.     

Estrogen accelerates gonadal recrudescence in photo-regressed male siberian hamsters

Seasonal gonadal recrudescence in the male Siberian hamster is accompanied by the initiation of spermatogenesis, weight gain, and darkening of coat color. The downstream endocrine regulators responsible for these changes have been definitively identified. We have previously shown that the administration of exogenous 17beta-estradiol (E(2)) to adult male Siberian hamsters kept under long-day photoperiod increased testicular mass without altering spermatogenesis. In this study, we examine if E(2) can initiate testicular growth in photo-regressed adult Siberian hamsters and if this testicular growth is accompanied by weight gain and pelage color change. Photo-regressed adult male Siberian hamsters were subcutaneously implanted with a 1 mm silastic capsule containing E(2) or cholesterol control. After 15 days, robust initiation of spermatogenesis was observed in E(2)-implanted animals in the absence of body weight and pelage color change. While circulating follicle-stimulating hormone (FSH) remained undetected in both control and E(2)-treated animals, E(2) significantly reduced pituitary gonadotropin stores. Overall, we showed E(2) stimulated gonadal recrudescence via a pathway that has diverged from body weight and pelage color change. Further, we demonstrated a novel role of E(2) in the initiation of spermatogenesis, possibly via a mechanism independent of FSH.     

The role of estrogen in cardiovascular disease

Cardiovascular disease is the number one cause of death among women, accounting for nearly 50% of female deaths. Statistics show that women on average develop cardiovascular disease 10 to 15 years later in life than men, and that the risk may increase after menopause. This observation has led to much speculation as to what physiological change(s) associated with menopause is responsible for the higher risk of atherosclerosis. Estrogen, with its potential as a cardioprotective agent and as an immunomodulator of the inflammatory response in atherosclerosis, has received the most attention. Understanding the mechanisms that lead to these differences may allow beneficial therapeutic intervention to enhance this effect in females and evoke this protection in males. This review will do the following: (1) characterize mechanisms of atherosclerosis, (2) explore the role of estrogen-replacement therapy, (3) define the effect of gender on inflammation, (4) compare and contrast the effects of estrogen and testosterone on endothelial functional, and (5) suggest mechanistic based therapeutic opportunities.     

In vivo autofluorescence spectroscopy of oral premalignant and malignant lesions: distortion of fluorescence intensity by submucous fibrosis

BACKGROUND AND OBJECTIVES: To test whether autofluorescence spectroscopy can be used for the diagnosis of oral neoplasia in a high-risk population, we characterized the in vivo autofluorescence spectra from oral submucous fibrosis (OSF) lesions and oral premalignant and malignant lesions in both OSF and non-OSF patients. STUDY DESIGN/MATERIALS AND METHODS: Autofluorescence emission spectra were measured under the excitation wavelength of 330 nm, using a Xenon lamp-based fluorospectrometer coupled to a handheld optical fiber probe. Autofluorescence spectroscopies were analyzed among patients with OSF lesions, and oral lesions of epithelial hyperkeratosis (EH), epithelial dysplasia (ED), and squamous cell carcinomas (SCC) and normal oral mucosa (NOM) of healthy volunteers. RESULTS: We found that the most intensely autofluorescence emission peaks occurred at 380 nm and 460 nm. For comparing the spectral patterns among different groups of oral lesions and NOM, ratios of the area under the spectrum of 460+/-10 nm to that under the spectrum of 380+/-10 nm (denoted as A(460+/-10nm)/A(380+/-10nm)) were calculated. The mean ratio values increased gradually from OSF to NOM, to EH and ED, and to SCC. The ANOVA test showed significant differences in the ratio value among all categories of samples (P<0.01). On the other hand, we found that EH, ED, and SCC lesions on OSF patients had distorted autofluorescence intensity. The mean ratio values of EH, ED, and SCC between non-OSF and OSF patients show significant differences. Furthermore, an ANOVA test showed NOM is not distinguishable from EH and ED lesions on oral fibrotic mucosa (P>0.05). CONCLUSIONS: Autofluorescence spectroscopy can be used to diagnose EH, ED, and SCC lesions in non-OSF patients but not in OSF patients.     

PLS-ANN based classification model for oral submucous fibrosis and oral carcinogenesis

BACKGROUND AND OBJECTIVES: For effective management of oral neoplasia, autofluorescence spectroscopy was conducted on patients with different characteristics of oral lesions in vivo. This study tested the possibility of using a multivariate statistical algorithm to differentiate human oral premalignant and malignant lesions from benign lesions or normal oral mucosa. STUDY DESIGN/MATERIALS AND METHODS: A fiber optics-based fluorospectrometer was used to measure the autofluorescence spectra from healthy volunteers (NOM) and patients with oral lesions of submucous fibrosis (OSF), epithelial hyperkeratosis (EH), epithelial dysplasia (ED), and squamous cell carcinoma (SCC). A partial least-squares and artificial neural network (PLS-ANN) classification algorithm was used to characterize these oral lesions to discriminate premalignant (ED) and malignant (SCC) tissues from "benign" (NOM, OSF, and EH) tissues. RESULTS: The normalized and centerized spectra of the different kinds of samples showed similar but divergent patterns. Our PLS-ANN classification algorithm could differentiate "premalignant and malignant" tissues from "benign" tissues with a sensitivity of 81%, a specificity of 96%, and a positive predictive value of 88%. CONCLUSIONS: We conclude that the PLS-ANN classification algorithm based on autofluorescence spectroscopy at 330-nm excitation is useful for in vivo diagnosis of OSF as well as oral premalignant and malignant lesions.